GU Cancers 2020 | Selecting immunotherapy for RCC

Yann-Alexandre Vano

Yann-Alexandre Vano, MD, Georges-Pompidou European Hospital, Paris, France, discusses his thoughts on immunotherapy combinations for renal cell cancer (RCC), highlighting a trial he was involved with called BIONIC, which studied the use of biomarkers to aid therapy choice. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter